Project Grant R01ES037701
- The National Institute of Environmental Health Sciences awarded Silent Spring Institute, Inc., $154,700 on August 28, 2026, under the NIEHS Superfund Hazardous Substances Basic Research and Education program (CFDA 93.143) to assess associations between per- and polyfluoroalkyl substance (PFAS) exposure from drinking water and hypertension and blood pressure among adults and children. The project will analyze measured and historically reconstructed serum PFAS concentrations in relation to blood...
- The National Institute of Environmental Health Sciences awarded the University of New England $163,856 on April 10, 2026, under the Environmental Health program (CFDA 93.113) to conduct a prospective study of per- and polyfluoroalkyl substance (PFAS) mixtures and pregnancy outcomes using data from the Study of Environment, Lifestyle, and Fibroids (SELF). The research leverages an existing cohort of reproductive-aged Black women from Detroit, Michigan, recruited between 2010 and 2012 when...
- Federal Project Grant Award Summary Brown University received a $463,850 Project Grant from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health program (CFDA 93.113), awarded on September 10, 2025, with a completion date of September 9, 2027. The award supports research investigating associations between prenatal per- and polyfluoroalkyl substances (PFAS) mixture exposure and long-term health outcomes in adulthood. The research leverages the New England...
- The National Institute of Environmental Health Sciences awarded George Washington University $158,955 on September 3, 2026, under the Environmental Health program (CFDA 93.113) to develop a place-based framework quantifying drinking water per- and polyfluoroalkyl substances (PFAS) mixture exposure and reproductive health risks. The research addresses the absence of a national framework to estimate drinking water PFAS mixture exposure and evaluate its impact on reproductive health at scale. Aim 1...
- The National Institute of Environmental Health Sciences awarded the University of Massachusetts $752,690 on August 13, 2026, for research on preconception and early pregnancy exposure to endocrine-disrupting chemicals under the Environmental Health grant program (CFDA 93.113). The project investigates how exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS), polybrominated diphenyl ethers (PBDEs), and trace elements affects women's reproductive health and the ability to achieve...
- The National Institute of Environmental Health Sciences awarded North Carolina State University $4,233,899 under the NIEHS Superfund Hazardous Substances Basic Research and Education program (CFDA 93.143) on August 1, 2026, to evaluate per- and polyfluoroalkyl substances (PFAS) exposure and associated metabolic health effects across three North Carolina communities with contaminated drinking water supplies. The research examines PFAS-induced dyslipidemia and obesity in approximately 1,000...
- The National Institute of Environmental Health Sciences awarded Trustees of Boston University $100,228 on December 28, 2026, under the Environmental Health program (CFDA 93.113) to conduct epidemiological research on persistent endocrine-disrupting chemical mixtures and maternal-infant health outcomes. Principal Investigator Noelle Henderson will quantify the impact of pre-conception maternal exposure to polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and organochlorine...
- The National Institute of Environmental Health Sciences awarded Harvard Pilgrim Health Care, Inc. $3.796 million on April 23, 2026, under the Environmental Health program (CFDA 93.113) to examine how early-life exposure to neighborhood environmental disadvantage and nephrotoxicants—including air pollutants and metals—associates with kidney function decline and elevated blood pressure across childhood and early adulthood. The research leverages Project Viva, an ongoing longitudinal pre-birth...
- The National Institute of Environmental Health Sciences awarded $818,402 to The Trustees of Columbia University in the City of New York on July 2, 2026, under the Environmental Health program (CFDA 93.113) to investigate the association between polycyclic aromatic hydrocarbon (PAH) exposure during reproductive windows of susceptibility and biomarkers of chronic disease risk in midlife women. The research leverages the Columbia Center for Children's Environmental Health Mothers and Newborns...
- Federal Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS) awarded the University of Massachusetts Lowell $157,437 under the Environmental Health program (CFDA 93.113) on May 10, 2025, for a two-year project concluding May 9, 2027. This Project Grant supports research defining the urinary, biliary, and fecal excretion pathways of diverse per- and polyfluoroalkyl substances (PFAS) and investigating the impact of dietary fiber on PFAS elimination. The research...
The National Institute of Environmental Health Sciences awarded Brigham & Women's Hospital Inc. $4,387,320 on August 5, 2026, under the Environmental Health program (CFDA 93.113) to conduct epidemiological research examining associations between per- and polyfluoroalkyl substances (PFAS) exposure and breast cancer risk in women. The research leverages the Nurses' Health Study, a prospective cohort of 121,701 U.S. women, analyzing paired water and plasma samples collected from approximately 32,000 participants in 1989–1990. The study will conduct targeted and non-targeted analyses to characterize personal PFAS exposure, assess associations between plasma PFAS concentrations and breast cancer risk stratified by menopausal and tumor receptor status, evaluate differential associations among specific PFAS mixtures characteristic of distinct exposure sources, and identify drinking water as a significant PFAS exposure pathway for the U.S. population. The research addresses gaps in epidemiologic evidence regarding PFAS carcinogenicity, particularly concerning mechanisms involving estrogen disruption and mammary gland toxicity. Performance occurs in Boston, Massachusetts. The period of performance runs from August 5, 2026, through August 4, 2030. The assistance type is a Project Grant under the NIEHS Environmental Health program, which supports epidemiological studies of health effects from environmental exposures, development of exposure assessment technologies, and mechanistic research on biological impacts of exposures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $4.4m | 8/4/26 |